Downloads

Tivdak patient resources

There are several useful tools available to help you throughout treatment with Tivdak

  • Patient Brochure

    An overview of Tivdak and what to expect from treatment.

    English

    Español

  • Eye Care Guide for Patients

    A guide to eye care while on treatment.

    English

    Español

  • Caregiver Brochure

    A resource providing guidance to caregivers about supporting their loved ones on Tivdak.

    English

    Español

  • TivdakTexts Brochure

    A guide to a text message support program designed to assist you throughout treatment.

    Download

  • Tivdak Discussion Guide

    FAQs and topics to review with your care team.

    Download

  • Tivdak Wallet Card

    A card informing healthcare teams that you’re on Tivdak.

    Download

TivdakTexts

Sign up for TivdakTexts

TivdakTexts is a text message support program designed to assist you throughout treatment

TivdakTexts overview

Some benefits of TivdakTexts include:

  • Infusion reminders

  • Eye drop reminders

  • Encouraging messages

To sign up for TivdakTexts, you should follow these steps:

  • Step 1: On your mobile phone, text the word JOIN to 74277

  • Step 2: When you get a message back from us, text back AGREE to confirm your participation in the support program

  • Step 3: Then answer 3 questions:

    • Your first name so we can personalize messages

    • Your ZIP Code so we can set your time zone

    • The timing of your upcoming Tivdak infusion

  • Message and data rates may apply. Check with your mobile service provider. Message frequency will be based on your selections. Text HELP for help with the program. Text STOP to stop receiving messages. See Terms of Use and Conditions. By initiating a text message, you agree to receive automated text messages from Seagen. You can unsubscribe at any time. You represent that you are the subscriber of the number provided and 18 or older. You must notify Seagen immediately if you relinquish the number provided. Consent is not required as a condition of purchasing any products or services.

FIND AN EYE SPECIALIST

Find an eye specialist

Work with your care team to find an eye specialist to check your eyes throughout treatment. You can also use this helpful tool to find an eye specialist near you.

This specialist can be either an optometrist or an ophthalmologist. Both are trained to perform an eye exam.

external-link

Video Library

Understanding Tivdak with the help of healthcare professionals

Get to Know Tivdak

Dr. Cecelia Boardman explains how Tivdak is thought to work.   

Caring for Your Eyes While on Tivdak

Nurse Practitioner B. Gail Hutzler gives an overview of Tivdak Required Eye Care.

How to apply eye drops

A healthcare professional from the American Academy of Ophthalmology walks you through the proper way to apply eye drops.

Get the support you need

Important Safety Information

What is the most important information I should know about TIVDAK?

Eye problems are common with TIVDAK and can be serious. TIVDAK can cause changes to the surface of your eye that can lead to dry eyes, eye redness, eye irritation, corneal ulcers, blurred vision, and severe vision loss. Tell your healthcare provider if you develop new or worsening vision changes or eye problems during treatment.

Your healthcare provider will send you to an eye specialist to check your eyes before you start treatment with TIVDAK, before each dose of TIVDAK, and as needed for any new or worsening signs and symptoms of eye problems.

Your healthcare provider will prescribe 3 different types of eye drops before you start treatment with TIVDAK. Bring the eye drops with you to each infusion and use them as directed by your healthcare provider to reduce your risk of eye problems:

  • You should use steroid eye drops before each infusion and as prescribed for 72 hours after each infusion

  • You should use vasoconstrictor eye drops right before each infusion

  • You should use lubricating eye drops throughout treatment and for 30 days after your last dose of TIVDAK

Do not wear contact lenses throughout your treatment with TIVDAK unless you are told to use them by your eye specialist.

What are the possible side effects of TIVDAK?

Serious side effects of TIVDAK may include:

Eye Problems. See "What is the most important information I should know about TIVDAK?"

Nerve problems (peripheral neuropathy) are common with TIVDAK and can be serious. Tell your healthcare provider right away if you have new or worsening numbness or tingling in your hands or feet or muscle weakness.

Bleeding problems (hemorrhage) are common with TIVDAK and can be serious. Tell your healthcare provider or get medical help right away if you have signs or symptoms of bleeding during treatment with TIVDAK including blood in your stools or black stools (looks like tar), blood in your urine, cough up or vomit blood, unusual vaginal bleeding, or any unusual or heavy bleeding.

Lung problems. TIVDAK may cause severe or life-threatening inflammation of the lungs that can lead to death. Tell your healthcare provider right away if you have new or worsening symptoms, including trouble breathing, shortness of breath, or cough.

Severe skin reactions. TIVDAK may cause severe or life-threatening skin reactions that can lead to death. Tell your healthcare provider or get medical help right away if you have signs or symptoms of a severe skin reaction during treatment with TIVDAK, including:

  • Skin reactions that look like rings (target lesions)
  • Rash or itching that continues to get worse
  • Blistering or peeling of the skin
  • Painful sores or ulcers in your mouth, nose, throat, or genital area
  • Fever or flu-like symptoms
  • Swollen lymph nodes

The most common side effects of TIVDAK include:

  • Decreased red blood cell and white blood cell counts

  • Tiredness

  • Nausea

  • Numbness or tingling in your hands or feet, or muscle weakness (peripheral neuropathy)

  • Hair loss (alopecia)

  • Nosebleed (epistaxis)

  • Eye problems (conjunctival disorders)

  • Bleeding (hemorrhage)

  • Changes in kidney function blood tests

  • Dry eye

  • Abnormal blood clotting test results

  • Diarrhea

  • Rash

Your healthcare provider may decrease your dose of TIVDAK, temporarily stop, or completely stop treatment if you have side effects.

What should I tell my healthcare provider before receiving TIVDAK?

Tell your healthcare provider about all your medical conditions, including if you:

  • have a history of vision or eye problems

  • have numbness or tingling in your hands or feet

  • have bleeding problems

  • have liver problems

  • are pregnant or plan to become pregnant; TIVDAK can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TIVDAK

  • are breastfeeding (nursing) or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for at least 3 weeks after the last dose of TIVDAK

    Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK

    • You should use an effective method of birth control during your treatment and for at least 2 months after the last dose of TIVDAK

    Males with female partners who are able to become pregnant:

    • You should use effective birth control during treatment and for 4 months after the last dose of TIVDAK

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TIVDAK with certain other medicines may cause side effects.

These are not all the possible side effects of TIVDAK. Discuss side effects with your healthcare provider. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.

Please see Important Facts about TIVDAK including IMPORTANT WARNING.

What is TIVDAK?

TIVDAK is a prescription medicine used to treat adults with cervical cancer:

  • that has returned or has spread to other parts of the body, and

  • who have received chemotherapy that did not work or is no longer working

TIVDAK was FDA approved based on a clinical study that measured how many patients had a tumor response and how long that response lasted. Continued approval is dependent on the results of an ongoing study to confirm the benefit of TIVDAK.

Important Safety Information

What is the most important information I should know about TIVDAK?

Eye problems are common with TIVDAK and can be serious. TIVDAK can cause changes to the surface of your eye that can lead to dry eyes, eye redness, eye irritation, corneal ulcers, blurred vision, and severe vision loss.

Important Safety Information

What is the most important information I should know about TIVDAK?

Eye problems are common with TIVDAK and can be serious. TIVDAK can cause changes to the surface of your eye that can lead to dry eyes, eye redness, eye irritation, corneal ulcers, blurred vision, and severe vision loss. Tell your healthcare provider if you develop new or worsening vision changes or eye problems during treatment.

Your healthcare provider will send you to an eye specialist to check your eyes before you start treatment with TIVDAK, before each dose of TIVDAK, and as needed for any new or worsening signs and symptoms of eye problems.

Your healthcare provider will prescribe 3 different types of eye drops before you start treatment with TIVDAK. Bring the eye drops with you to each infusion and use them as directed by your healthcare provider to reduce your risk of eye problems:

  • You should use steroid eye drops before each infusion and as prescribed for 72 hours after each infusion

  • You should use vasoconstrictor eye drops right before each infusion

  • You should use lubricating eye drops throughout treatment and for 30 days after your last dose of TIVDAK

Do not wear contact lenses throughout your treatment with TIVDAK unless you are told to use them by your eye specialist.

What are the possible side effects of TIVDAK?

Serious side effects of TIVDAK may include:

Eye Problems. See "What is the most important information I should know about TIVDAK?"

Nerve problems (peripheral neuropathy) are common with TIVDAK and can be serious. Tell your healthcare provider right away if you have new or worsening numbness or tingling in your hands or feet or muscle weakness.

Bleeding problems (hemorrhage) are common with TIVDAK and can be serious. Tell your healthcare provider or get medical help right away if you have signs or symptoms of bleeding during treatment with TIVDAK including blood in your stools or black stools (looks like tar), blood in your urine, cough up or vomit blood, unusual vaginal bleeding, or any unusual or heavy bleeding.

Lung problems. TIVDAK may cause severe or life-threatening inflammation of the lungs that can lead to death. Tell your healthcare provider right away if you have new or worsening symptoms, including trouble breathing, shortness of breath, or cough.

Severe skin reactions. TIVDAK may cause severe or life-threatening skin reactions that can lead to death. Tell your healthcare provider or get medical help right away if you have signs or symptoms of a severe skin reaction during treatment with TIVDAK, including:

  • Skin reactions that look like rings (target lesions)
  • Rash or itching that continues to get worse
  • Blistering or peeling of the skin
  • Painful sores or ulcers in your mouth, nose, throat, or genital area
  • Fever or flu-like symptoms
  • Swollen lymph nodes

The most common side effects of TIVDAK include:

  • Decreased red blood cell and white blood cell counts

  • Tiredness

  • Nausea

  • Numbness or tingling in your hands or feet, or muscle weakness (peripheral neuropathy)

  • Hair loss (alopecia)

  • Nosebleed (epistaxis)

  • Eye problems (conjunctival disorders)

  • Bleeding (hemorrhage)

  • Changes in kidney function blood tests

  • Dry eye

  • Abnormal blood clotting test results

  • Diarrhea

  • Rash

Your healthcare provider may decrease your dose of TIVDAK, temporarily stop, or completely stop treatment if you have side effects.

What should I tell my healthcare provider before receiving TIVDAK?

Tell your healthcare provider about all your medical conditions, including if you:

  • have a history of vision or eye problems

  • have numbness or tingling in your hands or feet

  • have bleeding problems

  • have liver problems

  • are pregnant or plan to become pregnant; TIVDAK can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TIVDAK

  • are breastfeeding (nursing) or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for at least 3 weeks after the last dose of TIVDAK

    Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK

    • You should use an effective method of birth control during your treatment and for at least 2 months after the last dose of TIVDAK

    Males with female partners who are able to become pregnant:

    • You should use effective birth control during treatment and for 4 months after the last dose of TIVDAK

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TIVDAK with certain other medicines may cause side effects.

These are not all the possible side effects of TIVDAK. Discuss side effects with your healthcare provider. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.

Please see Important Facts about TIVDAK including IMPORTANT WARNING.

What is TIVDAK?

TIVDAK is a prescription medicine used to treat adults with cervical cancer:

  • that has returned or has spread to other parts of the body, and

  • who have received chemotherapy that did not work or is no longer working

TIVDAK was FDA approved based on a clinical study that measured how many patients had a tumor response and how long that response lasted. Continued approval is dependent on the results of an ongoing study to confirm the benefit of TIVDAK.